Overexpression of TGF-β2 at the tumor–stroma interface correlates inversely with CD8+ density and promotes mesenchymal remodeling, resulting in “immuno-exclusive” zones devoid of effector cells [59]. The gene discussed is TGFB2; the disease is neoplasm.